Trials / Unknown
UnknownNCT03601988
Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer
A Randomized Phase III Trial of Postoperative Chemotherapy or Chemo-radiotherapy for Locally Advanced Gastric Cancer After D2 Resection
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 408 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the efficacy of adjuvant radiotherapy for D2 resected gastric cancer
Detailed description
The radiotherapy dose of 45Gy in 25 fractions as adjuvant treatment after D2 surgery for gastric cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Concurrent chemo-radiotherapy | Experimental group receive 6 cycles of XELOX chemotherapy and concurrent chemo-radiotherapy. The radiotherapy dose of 45Gy in 25 fractions delivered by IMRT Radiotherapy |
| DRUG | Chemotherapy | Chemotherapy group receive 8 cycles of XELOX. |
Timeline
- Start date
- 2018-07-28
- Primary completion
- 2020-07-28
- Completion
- 2022-07-28
- First posted
- 2018-07-26
- Last updated
- 2018-07-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03601988. Inclusion in this directory is not an endorsement.